era
travel
trade
increasingli
global
patient
consid
exot
infecti
diseas
restrict
develop
world
like
dengu
fever
ebola
chikungunya
present
clinic
emerg
room
north
america
europ
nonstop
flight
less
h
connect
world
major
airport
henc
physician
must
prepar
expect
unexpect
new
york
citi
exampl
million
passeng
annual
pass
john
f
kennedi
jfk
airport
intern
destin
traffic
volum
one
metropolitan
airport
alon
surpris
human
stowaway
passeng
like
mosquito
implic
transmiss
west
nile
viru
hiv
influenza
viru
mycobacterium
tuberculosi
sar
coronaviru
chikungunya
viru
exot
agent
also
transit
intern
legal
illeg
bushmeat
food
product
companion
anim
annual
traffic
bushmeat
charl
de
gaull
airport
pari
estim
tonn
work
nonhuman
primat
rodent
bat
bushmeat
seiz
jfk
wildlif
conserv
societi
ecohealth
allianc
center
diseas
control
prevent
found
evid
infect
retrovirus
herpesvirus
pathogen
bacteria
illeg
import
companion
anim
bird
primat
rodent
link
outbreak
poxvirus
salmonella
approxim
emerg
infecti
diseas
transmit
human
wildlif
domest
anim
major
zoonot
diseas
attribut
anthropogen
chang
loss
wildlif
habitat
develop
consumpt
bushmeat
necessit
poverti
due
cultur
prefer
increas
opportun
crossspeci
jump
global
warm
may
also
increas
geograph
rang
phlebotomu
insect
like
mosquito
tick
serv
reservoir
vector
infecti
agent
given
vertebr
speci
assum
averag
endem
virus
per
vertebr
speci
potenti
reservoir
vertebr
virus
estim
one
million
although
unlik
transmit
human
caus
diseas
sober
consid
challeng
detect
respond
even
novel
virus
aftermath
fall
twin
tower
septemb
new
york
citi
anthrax
attack
follow
mani
western
govern
becam
concern
bioterror
earli
invest
surveil
biolog
weapon
gave
way
surveil
emerg
infect
sober
reflect
led
recognit
latter
like
threat
public
health
howev
advanc
synthet
biolog
past
decad
dramat
clinician
public
health
practition
must
consid
possibl
highthreat
known
novel
pathogen
may
aris
deliber
genom
manipul
either
form
bioweapon
inadvert
releas
highthreat
human
pathogen
legitim
gainoffunct
research
wherebi
lowrisk
agent
becom
high
risk
scientif
larger
commun
current
grappl
implic
gainoffunct
research
context
experi
design
understand
virul
transmiss
avian
influenza
virus
establish
caus
link
viru
diseas
straightforward
complex
instanc
viru
respons
induct
diseas
present
site
organ
patholog
preced
relat
viru
caus
similar
diseas
classic
exampl
herp
enceph
detect
herpesviru
sequenc
polymeras
chain
reaction
pcr
cerebrospin
fluid
csf
patient
enceph
provid
clear
diagnosi
suggest
specif
therapeut
intervent
pcr
alon
inadequ
west
nile
enceph
pcr
csf
less
reliabl
assay
csf
igm
antibodi
viru
instanc
footprint
agent
found
adjac
affect
organ
detect
compart
pcr
detect
enteroviru
exampl
fece
patient
asept
mening
provid
strong
evid
enterovir
mening
despit
exampl
success
etiolog
agent
identifi
test
presum
viral
enceph
similar
figur
pertain
viral
pneumonia
sever
explan
surveil
diagnost
failur
instanc
problem
simpli
lack
access
appropri
sampl
infecti
agent
shed
saliva
nasopharyng
secret
blood
urin
csf
fece
may
detect
tissu
biopsi
altern
pathogenet
mechan
may
indirect
consequ
infect
may
delay
obscur
relationship
caus
agent
diseas
straightforward
mechan
viral
pathogenesi
cellular
damag
due
replic
lysi
apoptosi
autophagi
immun
respons
protein
express
infect
cell
howev
virus
also
induc
system
damag
cytokin
storm
result
shock
acut
respiratori
distress
andor
organ
failur
caus
immunosuppress
result
opportunist
infect
break
toler
self
result
autoimmun
diseas
infect
cryptic
impair
differenti
cell
function
like
hormon
secret
induc
neoplasia
impair
development
program
may
becom
appar
month
year
summari
challeng
viral
diagnost
develop
strategi
detect
footprint
agent
target
tissu
also
endur
shadow
infect
access
compart
mainstay
viral
diagnost
cultur
receiv
less
emphasi
clinic
microbiolog
chiefli
assay
requir
day
rather
hour
thu
inform
obtain
unlik
directli
impact
patient
manag
cultur
nonetheless
continu
play
import
role
public
health
well
basic
clinic
research
enabl
insight
pathogenesi
efficaci
drug
antibodi
vaccin
presenc
viru
detect
chang
cell
morpholog
level
light
microscopi
includ
lysi
round
syncytia
cell
reveal
increas
size
presenc
one
pathognomon
structur
electron
microscopi
viral
protein
bind
antibodi
reveal
immunohistochemistri
immunofluoresc
microscopi
wide
rang
cell
line
establish
cultur
virus
immort
other
primari
cultur
propag
gener
although
virus
grow
mani
cell
type
other
fastidi
requir
virus
never
cultur
despit
implic
diseas
instanc
propag
failur
may
overcom
adapt
serial
passag
presenc
second
permiss
type
cell
cocultiv
use
antibodi
rnai
suppress
innat
immun
respons
cell
obtain
genet
modifi
anim
howev
serial
passag
lead
adapt
includ
chang
virul
capac
viru
caus
diseas
tropism
cell
organ
viru
infect
inde
serial
passag
may
util
develop
less
virul
strain
use
vaccin
potenti
confound
character
sampl
may
contain
one
viru
cultur
environ
select
agent
fit
may
may
agent
interest
attempt
address
potenti
confound
well
propag
virus
fail
grow
simpl
cultur
investig
develop
cultur
includ
one
cell
type
instanc
complex
cultur
design
replic
architectur
organ
like
respiratori
tract
altern
cultur
cell
anim
inocul
advantag
anim
inocul
presenc
wide
rang
cell
type
associ
express
wide
rang
receptor
may
allow
viru
entri
investig
use
suckl
mice
innat
immun
respons
immatur
other
use
mice
genet
modifi
abrog
immun
respons
assay
design
detect
individu
virus
common
nat
employ
clinic
microbiolog
take
sever
form
quantit
realtim
pcr
wherein
nucleic
acid
replic
result
either
cleavag
releas
fluorescencelabel
probe
oligonucleotid
bind
sequenc
region
regular
forward
revers
primer
popular
continu
real
time
read
report
fluoresc
signal
afford
system
unpreced
dynam
rang
low
falseneg
rate
requir
equip
thermal
cycler
fluoresc
detector
laptop
comput
data
analysi
cost
competit
rug
batterypow
instrument
avail
field
use
loopmedi
isotherm
amplif
lamp
test
requir
programm
thermal
cycler
laboratori
lamp
product
detect
convent
dyestain
agaros
gel
field
applic
estim
product
accumul
turbid
dye
read
nake
eye
also
possibl
sensit
assay
highest
primer
andor
probe
sequenc
perfectli
match
select
singl
genet
target
fluorescencebas
taqman
molecular
beacon
assay
exampl
typic
detect
limit
molecul
per
assay
although
ideal
detect
quantit
specif
known
agent
assay
may
nonetheless
fail
templat
variabl
sequenc
composit
especi
affect
region
report
molecul
bind
particularli
challeng
diagnosi
rna
viru
infect
rna
virus
character
high
mutat
rate
includ
speci
high
genet
strain
variabl
comparison
consensu
pcr
assay
less
like
confound
sequenc
diverg
also
less
sensit
specif
pcr
assay
nest
pcr
test
employ
consensu
specif
primer
two
sequenti
amplif
reaction
either
one
heminest
two
fulli
nest
primer
locat
respect
first
primer
set
may
accommod
sequenc
variat
sensit
fluoresc
beaconbas
singleplex
assay
howev
wherea
quantit
fluoresc
beaconbas
realtim
assay
report
read
taken
indirectli
without
open
reaction
vessel
close
system
nest
pcr
system
bear
high
risk
contamin
transfer
amplifi
materi
first
second
nest
reaction
even
scrupul
experiment
hygien
observ
recent
autom
close
system
develop
allow
contaminationfre
transfer
separ
reaction
compart
singleus
cartridg
may
present
new
opportun
nest
assay
design
multiplex
pcr
assay
difficult
establish
singleplex
assay
primer
set
may
differ
optim
reaction
condit
eg
anneal
temperatur
magnesium
concentr
furthermor
complex
primer
mixtur
like
result
primerprim
interact
reduc
assay
sensit
andor
specif
advanc
multiplex
primer
design
develop
green
scprimer
softwar
program
autom
consensu
primer
design
multipl
sequenc
align
customiz
primer
length
melt
temperatur
degre
degeneraci
gelbas
multiplex
pcr
assay
limit
size
differenti
amplif
product
agaros
gel
concomit
requir
short
product
size
approx
base
pair
ensur
high
sensit
fidel
multiplex
achiev
fluoresc
beaconbas
realtim
assay
degre
differ
fluoresc
report
emiss
peak
unequivoc
separ
present
five
fluoresc
report
dye
detect
simultan
although
multiplex
may
increas
extent
doublelabel
strategi
andor
melt
curv
analys
sloppi
molecular
beacon
address
limit
part
bind
relat
target
differ
melt
temperatur
howev
suit
detect
target
differ
nucleotid
bioplex
luminex
platform
employ
flow
cytometri
detect
multipl
pcr
amplif
product
bound
match
oligonucleotid
attach
differ
color
fluoresc
bead
combin
multiplex
pcr
amplif
system
variou
protocol
direct
indirect
tagmedi
bead
hybrid
product
assay
panel
develop
permit
detect
approx
genet
target
simultan
commonli
use
respiratori
panel
rang
plex
like
realtim
pcr
assay
reli
assay
specif
threeoligonucleotid
interact
target
sequenc
therebi
limit
toler
mutat
variant
templat
compar
mass
spectroscopi
ms
coupl
platform
requir
two
oligonucleotidebind
site
masstag
pcr
ibi
system
two
platform
establish
combin
pcr
ms
sensit
simultan
detect
larg
number
target
ibi
system
use
matrixassist
laser
desorptionion
maldi
ms
directli
determin
molecular
weight
gener
pcr
product
compar
identif
databas
known
predict
product
weight
masstag
pcr
use
atmospher
pressur
chemic
ioniz
apci
ms
detect
molecular
weight
report
tag
attach
via
photocleav
linkag
pcr
primer
wherea
ibi
system
subsequ
electrospray
ioniz
esi
base
plexid
system
requir
analyt
ms
determin
exact
weight
pcr
product
thu
depend
advanc
mass
spectroscop
data
analysi
masstag
pcr
perform
use
smaller
instrument
requir
sophist
analys
record
known
mass
report
tag
use
given
multiplex
test
ibi
system
may
abl
alert
variant
known
organ
via
diverg
pcr
product
weight
like
masstag
pcr
requir
subsequ
sequenc
product
detail
character
wide
varieti
syndromespecif
masstag
pcr
panel
develop
appli
detect
virus
bacteria
fungi
parasit
associ
acut
respiratori
diseas
diarrhea
tickborn
diseas
encephalitidesmeningitid
hemorrhag
fever
although
multiplex
pcr
method
design
detect
known
agent
nonetheless
facilit
pathogen
discoveri
masstag
pcr
requir
two
differ
tag
primer
per
target
may
includ
degener
posit
address
genet
variat
larger
taxonom
group
whole
speci
genu
use
investig
influenzalik
ill
new
york
state
reveal
presenc
novel
rhinoviru
clade
employ
conserv
enterovirusrhinoviru
primer
set
discoveri
enabl
followup
studi
across
globe
wherein
third
speci
rhinoviru
rhinoviru
c
implic
influenzalik
ill
also
asthma
pediatr
pneumonia
otiti
media
wherea
multiplex
pcr
system
support
rapid
highthroughput
diagnosi
highest
sensit
limit
number
agent
microarraybas
system
provid
detect
known
pathogen
sequenc
inform
avail
expens
degre
sensit
modern
print
technolog
gener
highqual
array
sever
million
featur
print
densiti
enabl
detect
wide
rang
infecti
agent
also
discrimin
medic
import
type
subtyp
exampl
latter
applic
includ
respiratori
viru
resequenc
array
identifi
differ
influenza
viru
ha
na
subtyp
discoveri
array
platform
current
use
greenechip
virochip
panmicrobi
version
greenechip
address
virus
addit
pathogen
bacteria
fungi
parasit
led
recognit
plasmodium
falciparum
infect
case
unexplain
fatal
hemorrhag
fever
marburg
viru
outbreak
angola
variant
greenechip
facilit
recent
implic
reston
ebola
viru
respiratori
diseas
outbreak
pig
farm
philippin
virochip
support
character
sar
coronaviru
also
use
subsequ
diagnos
parainfluenza
viru
infect
human
metapneumoviru
variant
case
acut
respiratori
diseas
platform
reli
random
pcr
strategi
amplifi
label
nucleic
acid
detect
comparison
multiplex
consensu
pcr
method
employ
target
array
applic
resequenc
array
limit
sensit
especi
complex
sampl
type
tissu
specimen
exampl
sensit
may
exceed
copi
per
assay
host
pathogen
nucleic
acid
compet
pcr
reagent
thu
platform
success
sampl
contain
compar
low
level
compet
nucleic
acid
viru
cultur
supernat
serum
respiratori
specimen
spinal
fluid
urin
improv
sensit
rang
copi
per
assay
achiev
method
host
dna
digest
andor
deplet
host
ribosom
rna
rrna
prior
amplif
subtract
use
random
primer
select
lack
complementar
rrna
current
array
platform
viru
detect
achiev
via
fluoresc
report
direct
incorpor
fluoresc
nucleotid
pcr
product
bound
array
sandwich
approach
wherebi
fluorescentbranch
chain
dna
ad
product
bound
array
howev
new
array
develop
detect
viral
sequenc
chang
electr
conduct
platform
would
enhanc
portabl
elimin
need
fluoresc
scanner
may
also
increas
sensit
reduc
cost
elimin
need
pcr
amplif
highthroughput
sequenc
transform
microbiolog
enabl
discoveri
well
diagnost
unlik
pcr
array
method
investig
must
choos
pathogen
consid
limit
known
sequenc
inform
highthroughput
sequenc
potenti
simultan
detect
virus
also
bacteria
fungi
parasit
although
technolog
present
limit
special
laboratori
sequenc
becom
increasingli
access
instrument
becom
smaller
method
becom
user
friendli
cost
decreas
past
year
cost
decreas
per
nucleotid
per
nucleotid
even
impress
perhap
time
requir
gener
sequenc
data
project
requir
week
decad
ago
complet
hour
current
sequenc
platform
analyz
librari
amplifi
nucleic
acid
howev
platform
develop
capac
directli
sequenc
nucleic
acid
irrespect
platform
raw
sequenc
read
filter
qualiti
redund
assembl
contigu
sequenc
stream
stream
known
contig
well
read
assembl
align
databas
use
bioinformat
algorithm
examin
homolog
nucleotid
deduc
amino
acid
level
six
potenti
read
frame
align
allow
identif
known
novel
agent
well
detect
genet
featur
may
associ
drug
vaccin
resist
provid
insight
proven
evolut
find
nucleic
acid
footprint
viru
frequent
first
stage
implic
diseas
function
equival
virus
pathogen
island
found
bacteria
wherein
specif
sequenc
acquir
horizont
gene
transfer
confer
specif
pathogen
properti
best
establish
criteria
proof
causat
infecti
diseas
develop
late
koch
loeffler
known
koch
postul
stipul
agent
present
everi
case
diseas
specif
diseas
suffici
reproduc
diseas
cultur
inocul
naiv
host
river
suggest
develop
specif
immun
agent
follow
appear
diseas
could
use
demonstr
causat
adapt
origin
postul
molecular
era
fredrick
relman
later
establish
microbi
sequenc
may
use
surrog
cultur
actual
organ
lipkin
colleagu
recent
establish
level
confid
strength
associ
agent
diseas
consid
viral
burden
distribut
specif
immun
prevent
amelior
diseas
use
specif
drug
vaccin
given
sensit
molecular
method
imper
physician
research
consid
biolog
plausibl
assay
result
feasibl
pursu
confirm
independ
assay
particularli
engag
pathogen
discoveri
nat
rapidli
replac
classic
cultur
method
clinic
microbiolog
laboratori
although
nat
microarray
highthroughput
sequenc
still
requir
substanti
invest
equip
personnel
diagnost
platform
becom
access
less
expens
miniatur
improv
method
bioinformat
analysi
system
use
handheld
microarray
exampl
develop
ultim
enabl
diagnosi
bedsid
field
benchtop
sequenc
also
product
inevit
sequenc
cost
continu
decreas
clinician
seek
inform
concern
presenc
singl
candid
organ
also
predisposit
host
diseas
base
genet
factor
coinfect
microflora
improv
bring
dramat
benefit
medicin
public
health
